ANSM Drug & Device Safety Alert: Recall of Anti-Ig M-PER Reagent
Summary
The French ANSM has announced a recall of a specific lot of the Anti-Ig M-PER reagent used in Hydragel kits by Sebia. This safety action, registered under number R2607839, is intended for medical biology analysis laboratories.
What changed
The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding the recall of a specific lot of the Anti-Ig M-PER reagent, manufactured by Sebia, used in their Hydragel 6 CSF MD and Hydragel 6 CSF MS kits. This action, identified by recall number R2607839, is being implemented by the manufacturer and communicated to affected users via direct correspondence.
Medical biology analysis laboratories that have received the affected reagent lot must cease its use and follow the instructions provided by Sebia. While the ANSM is the issuing authority for the alert, direct inquiries and actions should be directed to Sebia. The document includes a link to the manufacturer's letter detailing the recall, dated March 25, 2026, which may contain specific instructions for return or disposal.
What to do next
- Cease use of the affected Anti-Ig M-PER reagent lot.
- Follow instructions provided by Sebia for recall procedures.
- Contact Sebia directly for any questions regarding the recall.
Archived snapshot
Mar 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Rappel n° R2607839 destiné aux laboratoires d'analyses de biologie médicale L'ANSM a été informée de la mise en œuvre du retrait d’un lot effectué par la société Sebia.
Les utilisateurs concernés ont reçu le courrier ci-joint.
Cette action de sécurité est enregistrée à l’ANSM sous le n° R2607839. Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Téléchargez le courrier de la société Sebia (25/03/2026)
Related changes
Get daily alerts for ANSM Drug & Device Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from ANSM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.